IBDEI0R5 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13391,2)
 ;;=^272402
 ;;^UTILITY(U,$J,358.3,13392,0)
 ;;=493.90^^87^834^10
 ;;^UTILITY(U,$J,358.3,13392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13392,1,4,0)
 ;;=4^493.90
 ;;^UTILITY(U,$J,358.3,13392,1,5,0)
 ;;=5^Asthma,Unspec
 ;;^UTILITY(U,$J,358.3,13392,2)
 ;;=^330091
 ;;^UTILITY(U,$J,358.3,13393,0)
 ;;=724.5^^87^834^13
 ;;^UTILITY(U,$J,358.3,13393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13393,1,4,0)
 ;;=4^724.5
 ;;^UTILITY(U,$J,358.3,13393,1,5,0)
 ;;=5^Back Pain NOS
 ;;^UTILITY(U,$J,358.3,13393,2)
 ;;=^12250
 ;;^UTILITY(U,$J,358.3,13394,0)
 ;;=600.00^^87^834^11
 ;;^UTILITY(U,$J,358.3,13394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13394,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,13394,1,5,0)
 ;;=5^BPH w/o Obstruction (LUTS)
 ;;^UTILITY(U,$J,358.3,13394,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,13395,0)
 ;;=490.^^87^834^15
 ;;^UTILITY(U,$J,358.3,13395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13395,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,13395,1,5,0)
 ;;=5^Bronchitis,Not Spec Acute or Chronic
 ;;^UTILITY(U,$J,358.3,13395,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,13396,0)
 ;;=682.8^^87^834^18
 ;;^UTILITY(U,$J,358.3,13396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13396,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,13396,1,5,0)
 ;;=5^Cellulitis Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,13396,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,13397,0)
 ;;=585.9^^87^834^20
 ;;^UTILITY(U,$J,358.3,13397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13397,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,13397,1,5,0)
 ;;=5^Chronic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,13397,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,13398,0)
 ;;=428.0^^87^834^16
 ;;^UTILITY(U,$J,358.3,13398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13398,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,13398,1,5,0)
 ;;=5^CHF,Unspec
 ;;^UTILITY(U,$J,358.3,13398,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,13399,0)
 ;;=496.^^87^834^17
 ;;^UTILITY(U,$J,358.3,13399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13399,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,13399,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,13399,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,13400,0)
 ;;=414.01^^87^834^21
 ;;^UTILITY(U,$J,358.3,13400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13400,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,13400,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,13400,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,13401,0)
 ;;=311.^^87^834^22
 ;;^UTILITY(U,$J,358.3,13401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13401,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,13401,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,13401,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,13402,0)
 ;;=250.01^^87^834^23
 ;;^UTILITY(U,$J,358.3,13402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13402,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,13402,1,5,0)
 ;;=5^Diabetes, Type 1 w/o Complication
 ;;^UTILITY(U,$J,358.3,13402,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,13403,0)
 ;;=250.00^^87^834^25
 ;;^UTILITY(U,$J,358.3,13403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13403,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,13403,1,5,0)
 ;;=5^Diabetes, Type 2 w/o Complication
 ;;^UTILITY(U,$J,358.3,13403,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,13404,0)
 ;;=305.90^^87^834^49
 ;;^UTILITY(U,$J,358.3,13404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13404,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,13404,1,5,0)
 ;;=5^Oth, Mixed, or Unspec Drug Abuse
 ;;^UTILITY(U,$J,358.3,13404,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,13405,0)
 ;;=305.93^^87^834^50
 ;;^UTILITY(U,$J,358.3,13405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13405,1,4,0)
 ;;=4^305.93
